Allergy Immunotherapy Market, by Treatment Type (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, and Others), by Distribution Channel (Hospital Pharm

Allergy Immunotherapy Market, by Treatment Type (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Immunotherapy is a preventive treatment for allergic reaction to substance such as grass pollens, house dust mites, and bee venom.
Subcutaneous immunotherapy (SCIT) and Sublingual immunotherapy (SLIT) are the immunotherapies used for the treatment of allergic rhinitis, allergic asthma, food allergy, venom allergy, and other allergies.
Subcutaneous immunotherapy (SCIT) is the most commonly used and effective form allergy immunotherapy.
Market Dynamics
The global allergy immunotherapy market is expected to witness significant growth over the forecast period, owing to increasing approval of allergy immunotherapy by regulatory authority.
For instance, in 2017, ALk, a pharmaceutical company focusing on prevention, treatment, and diagnosis of allergy, received the U.S. Food and Drug Administration Biologics License Application (BLA) for its house dust mite (HDM) sublingual allergy immunotherapy (SLIT) tablet Acarizax.
Furthermore, the tablet is also approved in Europe for the indication of house dust mite (HDM) for adults 18 through 65 years of age under the brand name Acarizax.
Key features of the study:
This report provides an in-depth analysis of the global allergy immunotherapy market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global allergy immunotherapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, and Jubilant HollisterStier
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global allergy immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy immunotherapy market
Detailed Segmentation:
Global Allergy Immunotherapy Market, By Treatment Type:
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
Global Allergy Immunotherapy Market, By Allergy Type:
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
Global Allergy Immunotherapy Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Allergy Immunotherapy Market, By Region:
North America
By Treatment Type
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
By Allergy Type
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country
U.S.
Canada
Latin America
By Treatment Type
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
By Allergy Type
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Treatment Type
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
By Allergy Type
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Treatment Type
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
By Allergy Type
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Treatment Type
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
By Allergy Type
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country
GCC
Israel
Rest of Middle East
Africa
By Treatment Type
Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)
By Allergy Type
Allergic Rhinitis
Allergic Asthma
Food Allergy
Venom Allergy
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Stallergenes Greer*
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
ALK-Abello A/S
Allergy Therapeutics
Allergopharma
HAL Allergy Group
Aimmune Therapeutics
DBV Technologies
Leti Pharma
Jubilant HollisterStier
“*” marked represents similar segmentation in other categories in the respective section.